|
End-of-day quote
Ghana S.E.
|
||
| - GHS | - |
|
| Market Cap | 5.2M 60.65M 4.59M 4.34M 3.93M 7.38M 499M 7.45M 52.05M 20.06M 255M 19.51M 19.09M 819M | P/E 2017 |
11.7x | P/E 2018 | 6.9x |
|---|---|---|---|---|---|
| Enterprise Value | 10.45M 122M 9.22M 8.72M 7.91M 14.83M 1B 14.98M 105M 40.33M 512M 39.22M 38.37M 1.65B | EV / Sales 2017 |
1.34x | EV / Sales 2018 | 1.05x |
| Free-Float |
26.89% | Yield 2017 * |
-
| Yield 2018 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | 915K | |
| -0.01% | +1.24% | +63.06% | +120.55% | 1,056B | |
| -1.61% | -0.60% | +47.32% | +71.79% | 645B | |
| -1.12% | -0.72% | +17.98% | +76.63% | 465B | |
| +0.20% | -3.58% | +34.74% | +41.18% | 335B | |
| +0.20% | +3.08% | +21.07% | +29.83% | 275B | |
| -0.80% | -0.64% | +10.45% | +12.79% | 255B | |
| +1.32% | +3.27% | +54.63% | +57.63% | 229B | |
| -0.61% | -0.91% | +34.33% | +101.87% | 188B | |
| -0.74% | -0.95% | -27.51% | -60.76% | 169B | |
| Average | +0.05% | -0.12% | +28.45% | +50.17% | 361.62B | |
| Weighted average by Cap. | +0.10% | +0.24% | +38.68% | +70.95% |
| 2017 | 2018 | |
|---|---|---|
| Net sales | 8.89M 104M 7.85M 7.43M 6.73M 12.62M 853M 12.75M 89.08M 34.33M 436M 33.39M 32.67M 1.4B | 9.91M 116M 8.75M 8.27M 7.5M 14.07M 951M 14.21M 99.26M 38.26M 486M 37.21M 36.4M 1.56B |
| Net income | 665K 7.76M 587K 555K 504K 944K 63.81M 953K 6.66M 2.57M 32.59M 2.5M 2.44M 105M | 762K 8.89M 672K 636K 577K 1.08M 73.07M 1.09M 7.63M 2.94M 37.31M 2.86M 2.8M 120M |
| Net Debt | 4.15M 48.41M 3.66M 3.46M 3.14M 5.89M 398M 5.95M 41.54M 16.01M 203M 15.57M 15.23M 654M | 5.25M 61.28M 4.63M 4.38M 3.98M 7.45M 504M 7.53M 52.59M 20.27M 257M 19.71M 19.28M 828M |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- SPL Stock
Select your edition
All financial news and data tailored to specific country editions
